KRAS and pancreatic neoplasm: Functional contributions of this phenotype were recently further identified in KRAS mutant PDAC progression; that is, enhanced macropinocytosis of extracellular fluids serves as a rapid amino acid supply route for pancreatic cancer cells9,10.